Bolus Intravenous Injection of Phosphorothioate Oligonucleotides Causes Hypotension by Acting as α1-Adrenergic Receptor Antagonists

This publication has 38 references indexed in Scilit:

• Telomerase Activity in Human Leukemic Cell Lines Is Inhibited by Antisense Pentadecadeoxynucleotides Targeted against c-myc mRNA
  Biochemical and Biophysical Research Communications, 1997
• Comparative Pharmacokinetics, Tissue Distribution, and Tumor Accumulation of Phosphorothioate, Phosphorodithioate, and Methylphosphonate Oligonucleotides in Nude Mice
  Antisense and Nucleic Acid Drug Development, 1997
• Effects of phosphodiester and phosphorothioate antisense oligodeoxynucleotides on cell lines which overexpress c-myc: Implications for the treatment of Burkitt's lymphoma
  Annals of Oncology, 1997
• Sequence-independent Effects of Phosphorothioated Oligonucleotides on Synaptic Transmission and Excitability in the Hippocampus In Vivo
  Neuropharmacology, 1997
• Inhibition of hepatitis B virus replication by targeted pretreatment of complexed antisense DNA in vitro
  Hepatology, 1996
• In VivoInhibition of Hepatitis B Virus Gene Expression by Antisense Phosphorothioate Oligonucleotides
  Biochemical and Biophysical Research Communications, 1996
• CpG motifs in bacterial DNA trigger direct B-cell activation
  Nature, 1995
• Pharmacokinetics of Antisense Oligonucleotides
  Clinical Pharmacokinetics, 1995
• Clinical Pharmacokinetics of Prazosin
  Clinical Pharmacokinetics, 1980
• Relationship between the inhibition constant (KI) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction
  Biochemical Pharmacology, 1973